SS Innovations International Inc. (NASDAQ: SSII) has brought robotic cardiac surgery to Sri Lanka through the launch of the country's first robotic cardiac surgery program at Kings Hospital Colombo, utilizing the SSi Mantra 3.0 surgical robotic system. The program commenced with a robotic-assisted left internal mammary artery (LIMA) takedown performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. This milestone was highlighted in a recent company video describing the program's early activity.
According to the video, Kings Hospital has completed more than 25 robotic procedures in just three weeks, demonstrating rapid adoption and proficiency with the SSi Mantra system. This achievement not only marks a significant advancement for Sri Lanka's healthcare sector but also underscores the global potential of robotic-assisted surgery to improve patient outcomes and expand access to minimally invasive techniques.
The launch in Sri Lanka is part of SS Innovations' broader international expansion. As of the end of the second quarter, the company reported 224 cumulative SSi Mantra installations across 12 countries. This growing installed base is translating into increased utilization: robotic procedures surged 143% year over year to 2,528, while second-quarter revenue reached $13.9 million. These figures indicate rising demand for the company's surgical robotic technologies and suggest a positive trajectory for future growth.
The next major corporate milestone for SS Innovations is regulatory expansion, with the company actively pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. Securing these approvals would open doors to two of the world's largest healthcare markets, potentially accelerating adoption and further driving revenue growth. The successful launch in Sri Lanka serves as a proof point of the system's capabilities and could bolster the company's case with regulators.
For investors, the news matters because it demonstrates SS Innovations' ability to penetrate new geographic markets and establish its technology in diverse healthcare settings. The rapid completion of 25 procedures in three weeks at Kings Hospital suggests strong local buy-in and efficient training, which are critical for scaling adoption. Moreover, the impressive procedure growth and revenue figures indicate that the company is effectively monetizing its installed base, a key metric for long-term success in the medical device industry.
The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.
